Comprehensive Psychiatry
Volume 48, Issue 6 , Pages 516-521 , November 2007

Eating disorders and illness burden in patients with bipolar spectrum disorders

Portions of this article were presented at the 2007 International Conference on Eating Disorders, Baltimore, MD, May 2-5, and the Seventh International Conference on Bipolar Disorder, Pittsburgh, PA, June 7-9, 2007.

References 

  1. Kruger S, Shugar G, Cooke RG. Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder. Int J Eat Disord. 1996;19:45–52
  2. Ramacciotti CE, Paoli RA, Marcacci G, Piccinni A, Burgalassi A, Dell'Osso L, et al. Relationship between bipolar illness and binge-eating disorders. Psychiatry Res. 2005;135:165–170
  3. McElroy SL, Kotwal R, Keck PE, Akiskal HS. Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?. J Affect Disord. 2005;86:107–127
  4. McElroy SL, Kotwal R, Keck PE. Comorbidity of eating disorders with bipolar disorder and treatment implications. Bipolar Disord. 2006;8:686–695
  5. Fairburn CG, Cooper Z. The eating disorder examination. In:  Fairburn CG,  Wilson GT editor. Binge eating: nature, assessment, and treatment. 12th ed.. New York: Guilford Press; 1993;p. 317–360
  6. Wildes JE, Marcus MD, Fagiolini A. Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder. [Under review].
  7. McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE, Leverich GS, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002;63:207–213
  8. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE, et al. An overview of recent findings of the Stanley Foundation Bipolar Network (part I). Bipolar Disord. 2005;5:310–319
  9. MacQueen GM, Marriott M, Begin H, Robb J, Joffe RT, Young LT. Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord. 2003;5:349–355
  10. Martin CK, Williamson DA, Thaw JM. Clinical validity of the multiaxial assessment of eating disorder symptoms. Int J Eat Disord. 2000;28:303–310
  11. Turner H, Bryant-Waugh R. Eating disorder not otherwise specified (EDNOS): profiles of clients presenting at a community eating disorder service. Eur Eat Disord Rev. 2004;12:18–26
  12. le Grange D, Binford RB, Peterson CB, Crow SJ, Crosby RD, Klein MH, et al. DSM-IV threshold versus subthreshold bulimia nervosa. Int J Eat Disord. 2006;39:426–467
  13. Striegel-Moore RH, Wilson GT, Wilfley DE, Elder KA, Brownell KD. Binge eating in an obese community sample. Int J Eat Disord. 1998;23:27–37
  14. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I Disorders (SCID-I). Washington (DC): American Psychiatric Press; 1995;
  15. Spearing MK, Post PM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73:159–171
  16. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed.. Washington (DC): Author; 1994;
  17. Ravaldi C, Vannacci A, Truglia E, Zucchi T, Mannucci E, Rotella CM, et al. The Eating Disorder Examination as a retrospective interview. Eat Weight Disord. 2004;9:228–231
  18. Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, et al. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatry. 2006;67:95–101
  19. Di Marzo S, Giordano A, Pacchiarotti I, Colom F, Sanchez-Moreno J, Vieta E. The impact of number of episodes on the outcome of bipolar disorder. Eur J Psychiatry. 2006;20:21–28
  20. Goodwin R, Stayner DA, Chinman MJ, Davidson L. Impact of panic attacks on rehabilitation and quality of life among persons with severe psychotic disorders. Psychiatr Serv. 2001;52:920–924
  21. Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, Pollice C, et al. Psychiatric disorders in women with bulimia nervosa and their first-degree relatives: effects of comorbid substance dependence. Int J Eat Disord. 1997;22:253–264
  22. Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003;160:112–117
  23. Frank E, Cyranowski JM, Rucci P, Shear MK, Fagiolini A, Thase ME, et al. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry. 2002;59:905–911
  24. Mond JM, Hay PJ, Rodgers B, Owen C. Eating Disorder Examination Questionnaire (EDE-Q): norms for young adult women. Behav Res Ther. 2006;44:53–62
  25. Agras WS, Walsh BT, Fairburn CG, Wilson GT, Kraemer HC. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Arch Gen Psychiatry. 2000;57:459–466
  26. Peterson CB, Mitchell JE. Psychosocial and pharmacological treatment of eating disorders: a review of research findings. J Clin Psychol. 1999;55:685–697
  27. Kawa I, Carter JD, Joyce PR, Doughty CJ, Frampton CM, Wells JE, et al. Gender differences in bipolar disorder: age at onset, course, comorbidity, and symptom presentation. Bipolar Disord. 2005;7:119–125
  28. Garfinkel PE, Lin E, Goering P, Spegg C, Goldbloom DS, Kennedy S, et al. Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups. Am J Psychiatry. 1995;152:1052–1058
  29. Hudson JI, Hiripi E, Pope HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey replication. Biol Psychiatry. 2007;61:348–358
  30. Striegel-Moore RH, Franko DL. Epidemiology of binge eating disorder. Int J Eat Disord. 2003;34:S19–S29
  31. Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry. 1999;40:57–87
  32. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med. 2006;68:684–691
  33. Cassano GB, McElroy SL, Brady K, Nolen WA, Placidi GF. Current issues in the identification and management of bipolar spectrum disorders in ‘special populations’. J Affect Disord. 2000;59:S69–S79
  34. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005;293:2528–2530
  35. Ranga K, Krishnan R. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67:1–8

 Dr Marcus has served as a consultant to GlaxoSmithKline and Sanofi Aventis. Dr Fagiolini is on the advisory board for Pfizer Inc and Bristol-Meyers Squibb and is in the speaker bureau of Bristol-Meyers Squibb, Eli Lilly Italy, Pfizer Inc, and Shire.

PII: S0010-440X(07)00076-4

doi: 10.1016/j.comppsych.2007.05.012

Comprehensive Psychiatry
Volume 48, Issue 6 , Pages 516-521 , November 2007